![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 8083 |
FusionGeneSummary for COPG2_PODXL |
![]() |
Fusion gene information | Fusion gene name: COPG2_PODXL | Fusion gene ID: 8083 | Hgene | Tgene | Gene symbol | COPG2 | PODXL | Gene ID | 26958 | 5420 |
Gene name | coatomer protein complex subunit gamma 2 | podocalyxin like | |
Synonyms | 2-COP|gamma-2-COP | Gp200|PC|PCLP|PCLP-1 | |
Cytomap | 7q32.2 | 7q32.3 | |
Type of gene | protein-coding | protein-coding | |
Description | coatomer subunit gamma-2coat protein, nonclathrin, gamma-2-copgamma-2-coat proteintesticular secretory protein Li 12 | podocalyxinGCTM-2 antigenpodocalyxin-like protein 1 | |
Modification date | 20180523 | 20180527 | |
UniProtAcc | Q9UBF2 | O00592 | |
Ensembl transtripts involved in fusion gene | ENST00000445977, | ENST00000541194, ENST00000537928, ENST00000378555, ENST00000322985, ENST00000465001, | |
Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 3 X 2 X 3=18 |
# samples | 3 | 3 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: COPG2 [Title/Abstract] AND PODXL [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | COPG2 | GO:0006891 | intra-Golgi vesicle-mediated transport | 11056392 |
Tgene | PODXL | GO:0030335 | positive regulation of cell migration | 18456258 |
Tgene | PODXL | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin | 18456258 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | STAD | TCGA-BR-4357-01A | COPG2 | chr7 | 130337709 | - | PODXL | chr7 | 131196192 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000445977 | ENST00000541194 | COPG2 | chr7 | 130337709 | - | PODXL | chr7 | 131196192 | - |
Frame-shift | ENST00000445977 | ENST00000537928 | COPG2 | chr7 | 130337709 | - | PODXL | chr7 | 131196192 | - |
Frame-shift | ENST00000445977 | ENST00000378555 | COPG2 | chr7 | 130337709 | - | PODXL | chr7 | 131196192 | - |
Frame-shift | ENST00000445977 | ENST00000322985 | COPG2 | chr7 | 130337709 | - | PODXL | chr7 | 131196192 | - |
5CDS-5UTR | ENST00000445977 | ENST00000465001 | COPG2 | chr7 | 130337709 | - | PODXL | chr7 | 131196192 | - |
Top |
FusionProtFeatures for COPG2_PODXL |
![]() |
Hgene | Tgene |
COPG2 | PODXL |
The coatomer is a cytosolic protein complex that bindsto dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosyntheticprotein transport from the ER, via the Golgi up to the trans Golginetwork. Coatomer complex is required for budding from Golgimembranes, and is essential for the retrograde Golgi-to-ERtransport of dilysine-tagged proteins. In mammals, the coatomercan only be recruited by membranes associated to ADP-ribosylationfactors (ARFs), which are small GTP-binding proteins; the complexalso influences the Golgi structural integrity, as well as theprocessing, activity, and endocytic recycling of LDL receptors (Bysimilarity). {ECO:0000250}. | Involved in the regulation of both adhesion and cellmorphology and cancer progression. Function as an anti-adhesivemolecule that maintains an open filtration pathway betweenneighboring foot processes in the podocyte by charge repulsion.Acts as a pro-adhesive molecule, enhancing the adherence of cellsto immobilized ligands, increasing the rate of migration and cell-cell contacts in an integrin-dependent manner. Induces theformation of apical actin-dependent microvilli. Involved in theformation of a preapical plasma membrane subdomain to set upinitial epithelial polarization and the apical lumen formationduring renal tubulogenesis. Plays a role in cancer development andaggressiveness by inducing cell migration and invasion through itsinteraction with the actin-binding protein EZR. Affects EZR-dependent signaling events, leading to increased activities of theMAPK and PI3K pathways in cancer cells.{ECO:0000269|PubMed:17616675, ECO:0000269|PubMed:18456258}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for COPG2_PODXL |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for COPG2_PODXL |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
COPG2 | COPB1, COPG1, MAGED1, DRD1, PMS2, MYC, ELAVL1, SIRT7, COPB2, COPA, COPG2, ARCN1, COPE, COPZ1, NDUFB8, ECT2, HES4, FBXO6, NUDCD1, STAU1, SHMT2, CD74, ATP1B2, HTR6, NTRK1, TMED10, HERC2, XPO1, MCM2, SNW1, CDC5L, SENP3, CDH1, PTPRD, TES | PODXL | SLC9A3R2, SELL, CDK2, NXF1, LGALS3, LGALS8, LGALS9, FCN1, PILRA, TMEM17, MRAP2, RHPN1, HSPA12A, NCR3LG1, IMPDH1, HSPA12B, SPAG9 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for COPG2_PODXL |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for COPG2_PODXL |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | COPG2 | C0043094 | Weight Gain | 1 | CTD_human |
Tgene | PODXL | C0007273 | Carotid Artery Diseases | 1 | CTD_human |
Tgene | PODXL | C0019080 | Hemorrhage | 1 | CTD_human |
Tgene | PODXL | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | PODXL | C0040053 | Thrombosis | 1 | CTD_human |